MedPath

CAP Pilot Study for Obstructive Sleep Apnea (OSA)

Completed
Conditions
Obstructive Sleep Apnea
Interventions
Other: CAP
Registration Number
NCT02309749
Lead Sponsor
Fisher and Paykel Healthcare
Brief Summary

This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is that the trial program will function as intended and average patient adherence will be over 4 hours per night.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria
  • Contraindicated for CPAP therapy
  • Medically unstable condition/diagnosis that is not yet under control
  • Co-existing sleep disorder (however clinically diagnosed insomnia can be included in the study)
  • Periodic Leg MOvement Arousal Index greater than 15/hr
  • Home titration of longer than 5 days

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Naive cohortCAP-
Primary Outcome Measures
NameTimeMethod
Accuracy of delivery of SMS messages to participant30 days

Cross check recieved messages logged in a diary by the participant to those sent by CAP

Secondary Outcome Measures
NameTimeMethod
Participant CPAP Adherence30 nights

Assess the adherence of participants to CPAP therapy while enrolled in CAP

Trial Locations

Locations (2)

Clayton Sleep Institute

🇺🇸

St Louis, Missouri, United States

Sleep Therapy Research Center

🇺🇸

San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath